Applying Novel Biomarkers to Assess Cardiac Risk in Patients Undergoing Major Vascular Surgery: Defining Iron, Oxidative Stress, Inflammation, Matrix Metalloproteinases, Coagulation Factors, Lipidomics, Endothelial Dysfunction and Other Relevant Markers as Novel Risk Predictors

Not Applicable

• Conditions: Coronary heart disease; Peripheral vascular disease; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12608000437369
• Lead Sponsor: The Alfred Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-08-29
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Patients >18 years of age. Vascular surgery either urgent, elective or semi-elective including: open repair of abdominal aortic aneurysm (AAA); supra-inguinal or infra-inguinal bypass or reconstructive surgery (e.g. aorto-bifemoral grafting).

Exclusion Criteria

Unwilling to consent. Myocardial infarction <6weeks. Percutaneous coronary intervention with bare stent <6weeks; or drug-eluting stent <12 months.

Study & Design

• Study Type: Observational
• Study Design: Not specified